Premier Path Wealth Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.08M | Buy |
9,769
+905
| +10% | +$100K | 0.15% | 164 |
|
2025
Q1 | $993K | Buy |
8,864
+812
| +10% | +$91K | 0.15% | 160 |
|
2024
Q4 | $744K | Buy |
8,052
+3,797
| +89% | +$351K | 0.11% | 184 |
|
2024
Q3 | $357K | Buy |
4,255
+926
| +28% | +$77.6K | 0.06% | 277 |
|
2024
Q2 | $228K | Sell |
3,329
-598
| -15% | -$41K | 0.04% | 337 |
|
2024
Q1 | $288K | Sell |
3,927
-995
| -20% | -$72.9K | 0.05% | 281 |
|
2023
Q4 | $399K | Buy |
+4,922
| New | +$399K | 0.09% | 217 |
|